FeBRUARY 2025 - Marisa Bartolomei
DNA Methylation Germline Reprogramming
November 2024 - Ryan Smith & VARUN DWARAKA
Leveraging DNA Methylation Biomarkers with TruDiagnostic
August 2024 - Giacomo Cavalli
The Role of Polycomb Proteins and 3D Genome Architecture in Epigenetics Inheritance and Cancer
May 2024 - Genevieve Fourel
ProA and ProB Repeat Sequences Shape Genome Organization in Eukaryotes, and Enhancers Open Chromatin Domains
March 2024 - Rong Fan
Spatial Epigenome Sequencing for Mapping Tissue Function, Aging and Diseases
February 2024 - Samir Ounzain
Unlocking the Regulatory Genome: Pioneering RNA-Guided Therapeutics for Cell-State Modulation in Disease Pathogenesis
NOVember 2023: Sir Shankar BalasubramaniAn (Univ. of Cambridge)
'DNA - What is it Telling Us?'
September 2023: Terry Connolly & Or Gozani (K36 Tx)
'Biology of NSD2 and Clinical Opportunities for KTX-1001,the First NSD2 Inhibitor to Enter the Clinic'
May 2023: John Rinn (Univ. Colorado)
'The Role of lncRNA in transcriptional regulation'
NOVEMBER 2022:
ALAN HUANG (Tango tx)
'Discovery of MTA-Cooperative PRMT5 Inhibitors for the Treatment of MTAP-Deleted Cancer'
AUGUST 2022
EMILY BERNSTEIN (Mount Sinai)
'Chromatin Remodeling in Cancer'
APRIL 2022
JOHN WHETSTINE (Fox Chase) - No Recording Available
'Epigenetics: A Gatekeeper to DNA Replication, Extrachromosomal DNA Amplification and Drug Response'
March 2022: Ronen Sadeh (Senseera)
'Cell-free chromatin sequencing as a new modality in liquid biopsy'
January 2022: Robert Copeland (Accent TX)
'Chromatin and RNA Modifying Enzyme Targets for Precision Cancer Therapeutics'